Drug Companies Thriving Amid Crisis As investors shy away from tech stocks, it looks like they're turning to pharmaceuticals. Third quarter earnings show that big U.S. drug companies did better than expected.
NPR logo

Drug Companies Thriving Amid Crisis

  • Download
  • <iframe src="https://www.npr.org/player/embed/96032130/96032108" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Drug Companies Thriving Amid Crisis

Drug Companies Thriving Amid Crisis

Drug Companies Thriving Amid Crisis

  • Download
  • <iframe src="https://www.npr.org/player/embed/96032130/96032108" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Biotech and pharmaceuticals are the latest stock market darlings. Third quarter earnings are out Thursday and big U.S. drug companies did better than expected. As investors shy away from tech stocks, it looks like they're turning to drug makers.

Related NPR Stories